Treatment of striae albae with combination of fractional radiofrequency and topical tretinoin: A randomized controlled trial
Lasers in Medical Science · 2026
DOI: 10.1007/s10103-026-04975-5 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Lasers in Medical Science, 2026. Verfasst von Gabriela Lladó Grove und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Copenhagen University Hospital - Bispebjerg, Copenhagen, Denmark. ggro0013@regionh.dk. Hauptthemen laut MEDLINE: Keratolytic Agents, Radiofrequency Therapy, Striae Distensae, Tretinoin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Hospital.
Abstract (Originalsprache)
Mature striae distensae, called striae albae, are common but treatment-resistant dermal scars. Fractional radiofrequency (FRF) can potentially act as transdermal permeation enhancer for topical tretinoin (TT). This study investigated FRF and TT as a combination treatment for striae albae. Twenty patients were included, each with four anatomically comparable areas that were randomized to (i) TT (ii) FRF (iii) combination FRF + TT and (iv) untreated control. Three treatment sessions were performed one month apart, and TT was also applied in-between. The change in striae from baseline to 20-week follow-up (Δ) was assessed using the Patient Observer Scar Assessment Scale (POSAS, SUM: 6–60). At baseline, patients assessed the striae as moderate-severe (POSAS-PT: SUM medians 24–25) and at follow-up, they reported an improvement (POSAS-PT: ΔSUM 5–10 points), but only the combination treatment improved significantly better (FRF + TT vs. control p = 0.029). A blinded dermatologist confirmed a tendency towards treatment improvement (POSAS-OBS: ΔSUM: 0–2 point, all treatments vs control p≥0.269). A subtle tendency was observed in objective measures with 3D photographs. Combination treatment with FRF and TT was tolerable and improved patient-reported striae compared to control. Striae albae remain challenging, but the findings highlight a potential for future combination treatment approaches. Trial registration number: NCT05461755 Date of registration: 15.07.2022
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Copenhagen University Hospital - Bispebjerg, Copenhagen, Denmark. ggro0013@regionh.dk.
- Department of Dermatology, Copenhagen University Hospital - Bispebjerg, Copenhagen, Denmark.
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
- Department of Dermatology, Aalborg University Hospital, Aalborg, Denmark.
Förderung
- National Hospital
Zitieren
APA
Grove, G. L., Karmisholt, K. E., Philipsen, P. A., Bjerring, P., & Haedersdal, M. (2026). Treatment of striae albae with combination of fractional radiofrequency and topical tretinoin: A randomized controlled trial. Lasers in Medical Science. https://doi.org/10.1007/s10103-026-04975-5
Vancouver
Grove GL, Karmisholt KE, Philipsen PA, Bjerring P, Haedersdal M. Treatment of striae albae with combination of fractional radiofrequency and topical tretinoin: A randomized controlled trial. Lasers in Medical Science. 2026. doi:10.1007/s10103-026-04975-5
BibTeX
@article{Grove2026,
author = {Grove, Gabriela Lladó and Karmisholt, Katrine E and Philipsen, Peter A and Bjerring, Peter and Haedersdal, Merete},
title = {Treatment of striae albae with combination of fractional radiofrequency and topical tretinoin: A randomized controlled trial},
journal = {Lasers in Medical Science},
year = {2026},
doi = {10.1007/s10103-026-04975-5}
}
EUVIMED